Abstract

Percutaneous Renal Biopsy in the Era of Precision Medicine: Challenges and Opportunities

Author(s): Arjun Yadav*

In the rapidly evolving landscape of nephrology, the traditional role of percutaneous renal biopsy is undergoing profound transformation as precision medicine takes center stage. While this procedure has long been the cornerstone for diagnosing a broad spectrum of renal diseases, it now faces a host of challenges in the era of precision medicine. Concerns over its invasiveness, potential complications, and the need for more precise diagnoses have come to the forefront. Yet, these challenges also open the door to a myriad of opportunities. Precision medicine offers the tantalizing prospect of tailoring treatment strategies to individual patients, based on the unique genetic and molecular characteristics of their renal diseases. Percutaneous renal biopsy, with its ability to provide crucial tissue specimens, emerges as a vital component in acquiring the necessary data for this approach. As such, it remains an indispensable tool, enabling personalized therapies, targeted interventions, and a deeper understanding of the underlying mechanisms driving renal diseases. This abstract underscores the pivotal juncture at which percutaneous renal biopsy finds itself, emphasizing the importance of collaborative efforts among nephrologists, pathologists, geneticists, and other stakeholders in harnessing its full potential in the era of precision medicine.